Acronym

LIVERATION

Title

Unravelling the impact of Radiofrecuency in liver surgery: the key to decrease local recurrence?

Duration

June 2023 – May 2028

GA Number

101104360

Programme

Horizon Europe

Action type

RIA

Call

HORIZON-MISS-2022-CANCER-01

Field

• Health
• Multistakeholder Engagement
• Social Innovation

Coordinator

Consorcio Mar Parc de Salut de Barcelona – IMIM

Description

LIVERATION aims to conduct an ambitious, pragmatic multicenter clinical trial with 720 patients with Colorectal cancer with liver metastases and hepatocellular carcinoma in more than 20 clinical centres in 6 different countries to determine whether additional ablated margin produced by radiofrequency can decrease the recurrence rate and improve patient survival. SHINE is involved in WP4 for social evaluation and comparative effectiveness of the intervention and in WP5 for dissemination, exploitation and communication.

Website

liveration.eu

Social Media

• https://www.linkedin.com/company/liverationeu/
• https://www.facebook.com/LiverationEU/
• https://www.instagram.com/liverationeu/
• https://x.com/liverationEU

Partners

• VECMEDICAL SPAIN SL

• Sociedad Para el Avance Cientifico – Society for the Improvement of Science – SACSIS

• SHINE 2Europe LDA

• European Liver Patients Association – ELPA

• Fundacion Avedis Donabedian para la Mejora de la Calidad ASISTENCIAL – FAD

• PANEPISTIMIO IOANNINON – UOI Research Committee

• ECRIN European Clinical Research Infrastructure Network – ECRIN